Improving Safety of Antivenom in People Bitten by Snakes
Study Details
Study Description
Brief Summary
A study to increase the safety of polyvalent antivenom involving 1000 patients in three centres: low dose adrenaline, promethazine, & hydrocortisone (alone and in combination) to prevent acute adverse reactions to antivenom in people bitten by snakes: randomised, double blind, placebo-controlled trial.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Study Design
Outcome Measures
Primary Outcome Measures
- Frequency of severe reactions to antivenom in the first 48 hours []
Secondary Outcome Measures
- Frequency of moderate & severe reactions to antivenom in the first 48 hours []
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Above 12 years of age
-
Patients admitted to hospital after snake bite in whom antivenom is indicated
-
Patients who give informed consent
Exclusion Criteria:
-
Patients who are pregnant or nursing
-
Patients who are currently taking beta- or alpha-adrenoceptor antagonists, or tricyclic antidepressants
-
Patients in whom adrenaline may be contraindicated (this may include patients with the following: history of ischaemic heart disease, stroke, uncontrolled hypertension, and tachyarrhythmias)
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Clinical Trials Unit, University of Kelaniya | Ragama | Sri Lanka |
Sponsors and Collaborators
- University of Kelaniya
Investigators
- Principal Investigator: Asita de Silva, University of Kelaniya
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 178A07